Chang Larry W, Alamo Stella, Guma Samuel, Christopher Jason, Suntoke Tara, Omasete Richard, Montis Jennifer P, Quinn Thomas C, Juncker Margrethe, Reynolds Steven J
Division of Infectious Diseases, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):276-82. doi: 10.1097/QAI.0b013e3181988375.
There is growing concern about the human resources needed to care for increasing numbers of patients receiving antiretroviral therapy in resource-limited settings. We evaluated an alternative model, community-based, comprehensive antiretroviral program staffed primarily by peer health workers and nurses.
We conducted a retrospective cohort study of patients receiving antiretroviral therapy during the first 10 months of program enrollment beginning in late 2003. Virologic, immunologic, clinical, and adherence data were collected.
Of 360 patients started on treatment, 258 (72%) were active and on therapy approximately 2 years later. Viral load testing demonstrated that 86% of active patients (211/246 tested) had a viral load <400 copies per milliliter. The median CD4 increase for active patients was 197 cells per cubic millimeter (interquartile range, 108-346). Patients with either a history of antiretroviral use or lack of CD4 response were more likely to experience virologic failure. Survival was 84% at 1 year and 82% at 2 years. World Health Organization stage 4 was predictive of both not sustaining therapy and increased mortality.
A community-based antiretroviral treatment program in a resource-limited setting can provide excellent AIDS care over at least a 2-year period. A comprehensive program based upon peer health workers and nurses provides an effective alternative model for AIDS care.
在资源有限的环境中,为越来越多接受抗逆转录病毒治疗的患者提供护理所需的人力资源问题日益受到关注。我们评估了一种替代模式,即主要由同伴健康工作者和护士组成的基于社区的综合抗逆转录病毒项目。
我们对2003年末开始项目登记的前10个月内接受抗逆转录病毒治疗的患者进行了一项回顾性队列研究。收集了病毒学、免疫学、临床和依从性数据。
在开始治疗的360名患者中,258名(72%)在大约2年后仍在积极接受治疗。病毒载量检测显示,86%的活跃患者(246名接受检测的患者中有211名)病毒载量<400拷贝/毫升。活跃患者的CD4中位数增加为每立方毫米197个细胞(四分位间距,108 - 346)。有抗逆转录病毒治疗史或CD4无反应的患者更有可能出现病毒学失败。1年生存率为84%,2年生存率为82%。世界卫生组织4期可预测治疗无法持续和死亡率增加。
在资源有限的环境中,基于社区的抗逆转录病毒治疗项目至少在2年时间内可以提供优质的艾滋病护理。基于同伴健康工作者和护士的综合项目为艾滋病护理提供了一种有效的替代模式。